Walleye Capital LLC Eliem Therapeutics, Inc. Transaction History

Walleye Capital LLC

$38.9 Billion
Q4 2024

A detailed history of Walleye Capital LLC transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 62,039 shares of ELYM stock, worth $254,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,039

Holding current value

$254,980

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 13, 2025	BUY	$4.11 - $5.42 $254,980 - $336,251	62,039 New	62,039 $254,000
Q2 2024 Aug 14, 2024	BUY	$2.6 - $10.2 $510,614 - $2 Million	196,390 New	196,390 $1.4 Million

Others Institutions Holding ELYM

# of Institutions

Shares Held

53.4M

Call Options Held

Put Options Held

Ra Capital Management, L.P. Boston, MA

31.4M
Shares

$129 Million
2.09% of portfolio
Janus Henderson Group PLC London, X0

3.18M
Shares

$13.1 Million
0.01% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

2.61M
Shares

$10.7 Million
3.29% of portfolio
Vanguard Group Inc Valley Forge, PA

1.51M
Shares

$6.19 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

1.04M
Shares

$4.27 Million
0.19% of portfolio

View Full List

About Eliem Therapeutics, Inc.

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

More about ELYM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account